School of Medicine
Showing 1,701-1,800 of 4,265 Results
-
Kathy Johnson
Executive Administrator, SPARK at Stanford
Current Role at StanfordProgram Administrator, SPARK at Stanford
Executive Admin to:
Daria Mochly-Rosen, Professor
Kevin V. Grimes, Professor - Teaching
Department of Chemical & Systems Biology -
Jamie S. Johnston
Research and Evaluation Director, Stanford Center for Health Education, Pediatrics - Infectious Diseases
BioJamie Johnston is the Research and Evaluation Director for the Stanford Center for Health Education. Her work focuses on the use of technology to improve educational access and health education in under-resourced areas. Jamie completed a PhD in Economics of Education at the Stanford Graduate School of Education in 2017, where she was an Institute of Education Sciences (IES) doctoral fellow. She also completed a postdoctoral fellowship with Stanford School of Medicine. Additionally, Jamie holds a BS in Social Policy from Northwestern University, an MPP from the University of Chicago, and an MA in Economics from Stanford University.
-
Semay Johnston
Affiliate, Technology & Digital Solutions
BioSemay Johnston is a board certified medical illustrator specializing in the visual communication of scientific and medical information through a variety of media. She believes that creative visualization provides a rare power to engage learners, simplify complexity, and inspire research. Previously, Semay worked at Macmillan Learning developing HTML5 interactive science modules and created surgical and anatomical illustrations at Body Scientific International. She holds an M.S. in Biomedical Visualization from the University of Illinois at Chicago.
-
Siddhartha Joshi, PhD
Sr Res Scientist-Basic Life, Neurosurgery
BioI am a neuroscientist with over 20 years of experience in empirical, hypothesis-driven research. My knowledge and expertise cover a wide range of topics and methods within systems neuroscience including sensory perception, neurophysiology and neuroanatomy, eye-movements and pupillometry. My research is focused on how the brain represents and uses sensory information to drive goal-directed behaviors and in exploring how intrinsic neuromodulatory systems influence the neural circuits that drive such behaviors. At Stanford, I am looking to channel my experience towards studying human neural signals that underlie computations governing pain and attention.
My work thus far [1-4] supports the idea that there is a need for simultaneous measurements of behavior, brain state and large-scale cortical activity to understand how the brain’s circuits: (i) are modulated by ascending sympathetic activation and (ii) provide top-down control of descending sympathetic control. These are technically challenging experiments [3,4] that have thus far largely been explored in animal models. My current goal is to leverage opportunities to directly measure human brain activity via electrodes implanted for monitoring epilepsy. Towards this end, I will use state-of-the-art neurophysiological, behavioral, pupillometric techniques combined with quantitative analyses.
Representative publications:
1. Joshi S, Gold JI (2020) Pupil Size as a Window on Neural Substrates of Cognition. Trends in Cognitive Sciences 24(6), 466-480. PMCID: PMC7271902.
2. Joshi S (2024). Control of Pupil Responses. Encyclopedia of the Human Brain (Elsevier), Second Edition, Vol.1, 374-387.
3. Joshi S, Li, Y, Kalwani R, Gold JI (2016). Relationships between pupil diameter and neuronal activity in the locus coeruleus, colliculi and cingulate cortex. Neuron 89:221-234. PMCID: PMC4707070.
4. Joshi S, Gold JI (2022) Context-Dependent Relationships between Locus Coeruleus Firing Patterns and Coordinated Neural Activity in the Anterior Cingulate Cortex. eLife 11:e63490. PMCID: PMC8765756. -
Neda Kaboodvand
Basic Life Res Scientist, Neurosurgery
Current Role at StanfordNeda Kaboodvand, PhD, is an Applied Research Scientist at Stanford University School of Medicine. Her research lies at the intersection of artificial intelligence, behavioral science, and clinical research, with a focus on using multimodal data to understand human behavior and improve clinical decision-making. She designs and leads experimental and observational studies and develops machine learning, statistical, and computational models to evaluate interventions, predict outcomes, and support personalized, adaptive approaches to care. A central part of her work involves modeling complex longitudinal and time-series data, including neural, electrophysiological, physiological, behavioral, imaging, and device-generated signals. By integrating these high-dimensional data sources, she develops models of patient and user state, identifies temporal patterns associated with outcomes and intervention response, and translates complex data into actionable insights for clinical and digital health systems.
-
Alexander D. Kaiser
Instructor, Cardiothoracic Surgery
BioAlexander Kaiser, PhD, is an applied mathematician and computational scientist who researches modeling and simulation of heart valves, focused on congenital heart valve disease and its surgical treatment. His recent research explores simulation-guided design of aortic valve repair of complex congenital heart defects. He has developed novel, nearly first-principles modeling methods for heart valves called elasticity-based design. These methods produce robust and realistic flows in fluid-structure interaction simulations. Dr. Kaiser is an Instructor in Cardiothoracic Surgery at Stanford University working with Michael Ma and Alison Marsden. He completed his PhD in Mathematics with Charles Peskin at the Courant Institute of Mathematical Sciences at New York University, where he was awarded the Kurt O. Friedrichs Prize for Outstanding Dissertation in Mathematics.
-
Sharada Kalanidhi
Director of Data Science, Biochemistry - Genome Center
Current Role at StanfordCurrent Research: Mathematical Medicine
The essential challenge is not merely to solve a problem, but to discover the mathematical framework in which the problem can be understood — a perspective associated with the mathematician Alexander Grothendieck.
We spent decades using sophisticated mathematics to understand financial markets. What happens when we bring that same mathematical direction—and deeper ideas from pure mathematics—to understanding human biology?
This question captures the intellectual motivation behind Sharada's current work: developing the foundations of Mathematical Medicine, a proposed new discipline that draws on pure mathematics to address fundamental challenges in individualized diagnosis, personalized therapeutics, cancer treatments, and healthy longevity.
The work begins with a central challenge in contemporary medicine. Advances in genomics, proteomics, metabolomics, and computational biology have generated unprecedented volumes of biomedical data. Yet translating these measurements into meaningful insights for individual patients remains difficult, particularly for those with rare, complex, or previously unexplained conditions.
Conventional statistical and machine learning approaches have transformed biomedical research, but their reliance on population-level patterns can limit their usefulness when an individual patient's biology differs substantially from that of available reference cohorts. Clinically meaningful differences may be treated as statistical noise or outliers rather than investigated as potential clues to underlying disease mechanisms.
After more than a decade of research and collaboration with biochemists at SGTC, Sharada became increasingly interested in whether the mathematical foundations used to interpret biomedical data were sufficient for the complexity of individualized medicine.
Her central premise is that progress in personalized medicine may require not simply more data or larger computational models, but new mathematical ways of understanding biological systems.
Rather than applying existing statistical approaches to biomedical problems, Mathematical Medicine explores whether ideas from pure mathematics can fundamentally change how biological questions are formulated, understood, and solved.
The research is guided by the possibility that deeper mathematical understanding can reveal - and preserve- meaningful biological relationships even when data are limited, heterogeneous, or difficult to interpret using conventional approaches.
This approach echoes a perspective expressed by the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.”
It also reflects the empirical philosophy associated with the mathematician and quantitative investor Jim Simons: “We don't start with models. We start with data. We don't have any preconceived notions.” The aim is to allow biological observations to guide mathematical inquiry, rather than forcing them into existing computational frameworks.
Sharada's research has contributed to investigations of complex and previously unexplained clinical conditions, including cases in which mathematical and multi-omic analyses helped identify potential diagnoses and therapeutic pathways. These investigations also motivate broader questions about how individual biological differences can inform our understanding of disease.
The long-term vision is to establish Mathematical Medicine as a rigorous discipline connecting pure mathematics, molecular biology, and clinical medicine—advancing mathematics toward a foundation for understanding individual biology, preserving biological mechanisms and informing clinical decisions.
Further information about Mathematical Medicine, its research vision, and opportunities for early philanthropic partnerships is available at:
https://mathmed-2026.web.app/ -
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Neil Kamdar
Assistant Director of Analytics, Center for Population Health Sciences
Biostatistician 3, Center for Population Health SciencesBioI am a health services researcher and applied methodologist focused on clinical and policy applications in disabilities research, women's health, general surgery, and mental health analyses. My focus has been on leveraging Medicare, private payer claims (Health Care Cost Institute (HCCI), MarketScan, OptumInsight, etc.) and Medicaid to understand cost, utilization, and outcomes. This work has been foundational in the development of large-scale studies on vulnerable populations that have typically been under-served or insufficiently studies in the health services research domain.
I serve as the Assistant Director of Analytics at the Center for Population Health Sciences at Stanford, focused on the development of the American Family Cohort (AFC) data, a primary care registry that provides substantial insights into clinical outcomes, utilization, and a particular focus on COVID-19 and Long COVID outcome analyses. Ancillary work would involve the development of research collaborations throughout Stanford Medicine with the interest in creating scholarship across the many domains of the Center for Population Health Sciences.
In addition to this role at Stanford, I also maintain an appointment at the University of Michigan, Institute for Healthcare Policy and Innovation, where I serve as an analytic lead in the development of administrative claims and electronic medical records analyses leading to publications in general and subject-specific journals.
I have been successful in being funded as a co-investigator with several federal and foundation agencies, including the National Institutes of Health (NIH), Department of Defense (DOD), Agency for Healthcare Research and Quality (AHRQ), Neilsen Foundation focused on traumatic spinal cord injury, among many others. I have also provided foundational analyses in the development of Clinical Quality Initiatives (CQIs), which are state-wide initiatives aimed at improving the health and efficiency of hospitals and institutions, with a focus on maternal and fetal medicine in the State of Michigan. -
Devanish Narasimhasanth Kamtam
Visiting Instructor, Cardiothoracic Surgery - Thoracic Surgery
BioDr. Devanish Kamtam is a Visiting Instructor in the Division of Thoracic Surgery at Stanford University, working in Dr. Joseph Shrager's lab. His research focuses on surgical AI, AI in medical imaging, and clinical outcomes in Thoracic Surgery. He completed his MBBS at Gandhi Medical College, Hyderabad and MS in General Surgery at AIIMS New Delhi.
-
Jennifer Kang
Academic Prog Prof 2, Pediatrics - Infectious Diseases
Current Role at StanfordProgram Manager, Global Child Health Program
-
Merve Kaptan. PhD
Basic Life Research Scientist, Anesthesia - Adult Pain Medicine
BioDr. Kaptan is a researcher with a background in psychology and neuroscience whose work focuses on methodological innovation in quantitative MRI to characterize the structure and function of the brain, spinal cord, and musculoskeletal system. Her research aims to develop imaging markers for neurological, musculoskeletal, and chronic pain disorders.
-
Ziya Karimov
Visiting Instructor, Neurosurgery Research
BioZiya Karimov, MD, MSc is a Neurosurgery Postdoctoral Scholar at the Department of Neurosurgery, Stanford University School of Medicine. He graduated with an Honours Degree from Ege University Faculty of Medicine (6 years med school, including 1 year Internship) in Izmir, Türkiye. Dr. Karimov ranked top percentile in the Turkish Medical Specialty Exam (TUS) and started the Residency at Izmir City Hospital (4th largest hospital in Türkiye). He gained neurosurgery experience in the US top-level centers - Johns Hopkins University, Barrow Neurological Institute, and Lenox Hill Hospital.
Dr. Karimov is interested in Cerebrovascular Surgery, Skull Base Surgery, Neurosurgery Education, and Cognitive and Behavioral Neuroscience.
He plans to be a Surgeon-Scientist and teacher, and build up new programs.
Dr. Karimov serves as a peer-reviewer in Springer-Nature, Cureus, Lippincott, MDPI, and other trusted publishers.
He is a Licensed Judo Athlete.
Hobbies: Judo, swimming, volleyball, intellectual contest games, brain ring -
Max Kasun
Research Professional, Psychiatry and Behavioral Sciences
BioMax Kasun works in the Roberts Ethics Lab and Kim Ethics Lab at Stanford, which use empirical methods to help anticipate, clarify and resolve ethical issues in modern biomedical research. He has interests in empirical and normative thought dedicated to increasing scientific understanding and societal appreciation of the nature, internal experience, and prevalence of mental illness and well-being, as well as in moral philosophy (e.g. justice, action, capability, neo-Aristotelianism, and pragmatism), cognitive and affective sciences, and philosophy of mind (e.g. embodiment and personhood). He has co-authored scientific, peer-reviewed articles and other scholarly work investigating ethical issues in research (e.g. authentic voluntarism in informed consent), medical education, public health, and neuroscience. His most recent contributions to NIH-funded scientific work (National Center for Advancing Translational Sciences; PI: Dr. Jane Kim) have focused on investigating ethical issues encountered in the design, development, and clinical integration of artificial intelligence, e.g., how environmental and cognitive factors shape appraisals of AI tools, clinical judgments, trust, and health decision-making.
Max is a co-author of several chapters in APA's Study Guide to DSM-5-TR (2024) including the chapters on bipolar and related disorders and personality disorders (American Psychiatric Association). He has published work in and provided editorial support for the peer-reviewed journal Academic Medicine (Oxford University Press) and for two works on the subject of trauma and crisis and related interventions, including a reference guide for providing mental health care to victims of state atrocity (United Nations, Springer). Previously, he served on leadership teams for the Stanford Mental Health Technology and Innovation Hub and Neurodiversity Project.
Max is currently working to develop a new Special Initiative of the Chair on Mental Health Care for Unhoused and Justice-Involved Persons (see https://med.stanford.edu/psychiatry/special-initiatives/mhuj.html). The initiative aims to bring together a community of scholars, public stakeholders, and health care professionals to help advance more humane and participatory inquiry and health policy in service of a population that faces profound controversy, health stigma, and scientific neglect. The initiative aims to improve how science is communicated to the public and policy decision-makers and to develop more evidence-based, pragmatic, strengths-based, and trauma-informed approaches to mental health care for unhoused persons, including those who have experienced episodic or cyclical involvement in the criminal and civil justice systems. -
Ankita Kaulberg
Director of Innovation & Technology, Epidemiology and Population Health
Current Role at StanfordDirector of Innovation & Technology, HEARTS Lab
Stanford School of Medicine -
Dr Mohit Kaushal MD
Adjunct Professor, Biomedical Data Science
BioDr. Mohit Kaushal is an accomplished entrepreneur, investor, and physician with a distinguished career spanning clinical medicine, academia, public policy and industry. He has served as an investor and board member for numerous public and private transformative companies, including Oak Street Health (NYSE: OSH, acquired by CVS Health, NYSE: CVS), Humedica (acquired by Optum, NYSE: UNH), RxAnte (acquired by Millennium), Change Healthcare (acquired by Emdeon), Universal American (NYSE: UAM, acquired by WellCare, NYSE: WCG), goBalto (acquired by Oracle, NYSE: ORCL), CitiusTech (acquired by Baring), Wellframe (acquired by HealthEdge), and George Clinical (acquired by Hillhouse).
During the Obama administration, Dr. Kaushal served on the White House Health IT Task Force, contributing to the implementation of the Affordable Care Act’s technology initiatives and testifying before Congress on the role of technology and payment reform in Medicare. He also established and led the first dedicated healthcare team at the Federal Communications Commission, where his work included partnering with the FDA to streamline regulation of converged telecommunications, analytics, and medical devices, ultimately resulting in the FDA’s mobile medical applications guidance. His team also restructured the Rural Healthcare Fund into the Healthcare Connect Fund, aligning its resources with broader healthcare technology and payment reforms.
In academia, Dr. Kaushal is an Adjunct Professor in the Department of Biomedical Data Science at Stanford University, which integrates AI, biomedical informatics, biostatistics and computer science to advance precision health. His teaching emphasizes the application of data—ranging from molecular and tissue-level information to imaging, EHR, biosensors, and population health—to improve medical outcomes.
He remains active in public policy as a Scholar in Residence at the Duke-Margolis Center for Health Policy and was previously a Visiting Scholar at the Brookings Institution. His policy work includes previous appointments to the FDASIA Workgroup of the Health IT Policy Committee and the National Committee on Vital and Health Statistics, advising HHS on data access and use.
Dr. Kaushal is an emergency physician by training, holds an MBA from Stanford University, and earned his MD with distinction from Imperial College London. -
Micah Kelly
Radiation and Cancer Biology Administrative Programs Lead, Radiation Oncology - Radiation Biology
Current Role at StanfordAdministrative Associate to Drs. Erinn Rankin, Ted Graves, and Laura Attardi.
-
Samantha M Kerath
Director of Finance and Administration, Microbiology and Immunology
Current Role at StanfordDirector of Finance & Administration
Microbiology & Immunology and Baxter Lab